Comparative Effectiveness Study of Chloramphenicol and Ceftriaxone in the Treatment of Typhoid Fever in Children Admitted to Putri Hijau Kesdam I/Bb Hospital Medan
- PMID: 32127989
- PMCID: PMC7048335
- DOI: 10.3889/oamjms.2019.517
Comparative Effectiveness Study of Chloramphenicol and Ceftriaxone in the Treatment of Typhoid Fever in Children Admitted to Putri Hijau Kesdam I/Bb Hospital Medan
Abstract
Background: Typhoid fever is a disease caused by Salmonella typhi bacteria, especially attacking the digestive tract. Chloramphenicol is the main drug of choice for the treatment of typhoid fever. But along with the advancement of the medical field, other medicines were developed. Ceftriaxone is an effective drug for the treatment of typhoid fever in the short term. But the price of ceftriaxone is more expensive.
Aim: The aim of this study was comparative effectiveness study of Chloramphenicol and Ceftriaxone in the treatment of typhoid fever in children admitted to Putri Hijau Kesdam I/BB Hospital Medan.
Methods: This study was conducted cross-sectionally about the treatment of typhoid fever in children who were hospitalized at TK II PutriHijau Hospital Kesdam I/BB Medan. the patient used cloramfenikol antibiotics in 13 patients and used ceftriaxone in 17 patients. Patient age ranges from 0-19 years. Antibiotic analysis is the best effectiveness using the ACER method.
Results: He results of the patient characteristics show that the children of patients who suffer from typhoid fever, the highest age is 12-16 years (50%), by gender male 60% and female 40%. Patients hospitalized using chloramfenicol averaged 6.53 days (7 days) while ceftriaxon averaged 4.17 days. The average number of direct medical costs in pediatric patients suffering from typhoid fever using cloramfenikol was 3,212,776/patient while ceftriaxon 1,967,045/patient. Cost effectiveness analysis using ACER method obtained results for cloramenicenicol at 492.002/day and ceftriaxon 471,713/day.
Concluson: Ceftriaxone has a better treatment effectiveness compared to chloramphenicol in typhoid fever patients in children.
Keywords: Ceftriaxone; Chloramphenicol; Cost Effectiveness; Typhoid Fever.
Copyright: © 2019 Eva Sartika Dasopang, Fenny Hasanah, Teddy Kurniawan Bakri, Muktia Isma.
Similar articles
-
Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.Antimicrob Agents Chemother. 1993 Aug;37(8):1572-5. doi: 10.1128/AAC.37.8.1572. Antimicrob Agents Chemother. 1993. PMID: 8215265 Free PMC article. Clinical Trial.
-
Treatment of typhoid fever in children with a flexible-duration of ceftriaxone, compared with 14-day treatment with chloramphenicol.Int J Antimicrob Agents. 2003 Apr;21(4):350-3. doi: 10.1016/s0924-8579(02)00388-6. Int J Antimicrob Agents. 2003. PMID: 12672582 Clinical Trial.
-
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.Indian J Med Res. 2001 Jun;113:210-3. Indian J Med Res. 2001. PMID: 11816954
-
Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins.Rev Infect Dis. 1987 Jul-Aug;9(4):719-36. doi: 10.1093/clinids/9.4.719. Rev Infect Dis. 1987. PMID: 3125577 Review.
-
Typhoid fever presenting as acute psychosis in a young adult: case report and literature review of typhoid psychosis.Trop Biomed. 2021 Jun 1;38(2):192-195. doi: 10.47665/tb.38.2.057. Trop Biomed. 2021. PMID: 34172710 Review.
Cited by
-
A systematic review of recent outbreaks and the efficacy and safety of drugs approved for the treatment of Salmonella infections.IJID Reg. 2024 Dec 6;14:100516. doi: 10.1016/j.ijregi.2024.100516. eCollection 2025 Mar. IJID Reg. 2024. PMID: 39866847 Free PMC article. Review.
References
-
- Verma R, Bairwa M, Chawla S, Prinja S, Rajput M. New generation typhoid vaccines:An effective preventive strategy to control typhoid fever in developing countries. Human Vaccines. 2011;7(8):883–5. https://doi.org/10.4161/hv.7.8.16282 PMid:21791973. - PubMed
-
- Mintz E, Slayton R, Walters M. Typhoid Fever and Paratyphoid Fever. Control of Communicable Diseases Manual. 2015 https://doi.org/10.2105/CCDM.2745.149.
-
- Zaki SA, Karande S. Multidrug-resistant typhoid fever:a review. The Journal of Infection in Developing Countries [Internet] Journal of Infection in Developing Countries. 2011;5:05. https://doi.org/10.3855/jidc.1405 PMid:21628808. - PubMed
-
- Stoesser N, Eyre D, Basnyat B, Parry C. Treatment of enteric fever (typhoid and paratyphoid fever) with third and fourth generation cephalosporins. Cochrane Database of Systematic Reviews. 2013:3. https://doi.org/10.1002/14651858.CD010452. - PMC - PubMed
-
- News in brief. Expert Review of Pharmacoeconomics & Outcomes Research. 2013;13(1):5–7. https://doi.org/10.1586/erp.13.2. - PubMed
LinkOut - more resources
Full Text Sources